Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Halozyme Therapeutics Inc (HALO)

  • Business News
  • Nov. 07, 2025, 04:38 UTC

Halozyme - Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032

Full text
Register to leave comments
There are no comments here yet...

Search

News categories

  • Technical Exchange News(10969)
  • Event(2441)
  • SEC News(193597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125911)
© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin